GAM
FLGT icon

Griffin Asset Management’s Fulgent Genetics FLGT Stock Holding History

Griffin Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,289
Closed -$202K – 210
2022
Q3 		$202K Sell
5,289
-600
-10% -$30.1K 0.03% 196
2022
Q2 		$321K Hold
5,889
– – 0.05% 176
2022
Q1 		$368K Sell
5,889
-100
-2% -$6.58K 0.05% 179
2021
Q4 		$602K Buy
5,989
+190
+3% +$16.7K 0.07% 162
2021
Q3 		$522K Sell
5,799
-2,521
-30% -$229K 0.07% 170
2021
Q2 		$767K Sell
8,320
-5,913
-42% -$472K 0.09% 158
2021
Q1 		$1.38M Buy
+14,233
New +$1.47M 0.18% 120

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Griffin Asset Management's FLGT Position: Q4 2022 in Review

Griffin Asset Management sold out of Fulgent Genetics (FLGT) in Q4 2022, closing a stake of 5,289 shares — an estimated $202K sold.

Griffin Asset Management first reported a position in FLGT in Q1 2021 and held it in 7 quarters. The position peaked at $1.38M in Q1 2021. 224 funds tracked by Wall St. Rank hold FLGT as of Q4 2022.

  • Griffin Asset Management reported no remaining Fulgent Genetics position as of Q4 2022 after selling out during the quarter.
  • Griffin Asset Management sold 5,289 Fulgent Genetics shares in Q4 2022, an estimated $202K.
  • Griffin Asset Management first reported a position in Fulgent Genetics in Q1 2021 and held it in 7 quarters.
  • Griffin Asset Management's Fulgent Genetics position peaked at $1.38M in Q1 2021.
  • 224 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2022.

Based on Griffin Asset Management's 13F filing for Q4 2022, filed 20 Jan 2023.